Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Photoaffinity labeling of P-glycoprotein.

Peer M, Csaszar E, Vorlaufer E, Kopp S, Chiba P.

Mini Rev Med Chem. 2005 Feb;5(2):165-72. Review.

PMID:
15720286
2.
3.

Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.

Borchers C, Boer R, Klemm K, Figala V, Denzinger T, Ulrich WR, Haas S, Ise W, Gekeler V, Przybylski M.

Mol Pharmacol. 2002 Jun;61(6):1366-76.

PMID:
12021398
4.

Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein.

Safa AR.

Methods Enzymol. 1998;292:289-307. No abstract available.

PMID:
9711562
5.

Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.

Isenberg B, Thole H, Tümmler B, Demmer A.

Eur J Biochem. 2001 May;268(9):2629-34.

6.

Identification of drug interaction sites in P-glycoprotein.

Greenberger LM.

Methods Enzymol. 1998;292:307-17. No abstract available.

PMID:
9711563
7.

Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding.

Dey S, Ramachandra M, Pastan I, Gottesman MM, Ambudkar SV.

Methods Enzymol. 1998;292:318-28. No abstract available.

PMID:
9711564
8.

Both ATP sites of human P-glycoprotein are essential but not symmetric.

Hrycyna CA, Ramachandra M, Germann UA, Cheng PW, Pastan I, Gottesman MM.

Biochemistry. 1999 Oct 19;38(42):13887-99.

PMID:
10529234
10.

Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein.

Booth CL, Pulaski L, Gottesman MM, Pastan I.

Biochemistry. 2000 May 9;39(18):5518-26.

PMID:
10820025
11.
12.

Photoaffinity labelling of P-glycoprotein catalytic sites.

Sankaran B, Bhagat S, Senior AE.

FEBS Lett. 1997 Nov 3;417(1):119-22.

13.

Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: structure-activity relationships for flavonoid binding.

de Wet H, McIntosh DB, Conseil G, Baubichon-Cortay H, Krell T, Jault JM, Daskiewicz JB, Barron D, Di Pietro A.

Biochemistry. 2001 Aug 28;40(34):10382-91.

PMID:
11513617
14.

Photoaffinity Labeling of Plant Receptor Kinases.

Shinohara H, Matsubayashi Y.

Methods Mol Biol. 2017;1621:59-68. doi: 10.1007/978-1-4939-7063-6_6.

PMID:
28567643
15.

Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).

Chen KG, Lacayo NJ, Durán GE, Cohen D, Sikic BI.

Mol Pharmacol. 2000 Apr;57(4):769-77.

PMID:
10727524
16.

Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.

Boer R, Ulrich WR, Haas S, Borchers C, Gekeler V, Boss H, Przybylski M, Schödl A.

Eur J Pharmacol. 1996 Jan 11;295(2-3):253-60.

PMID:
8720592
17.

A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and P-glycoprotein.

Ojima I, Duclos O, Dormán G, Simonot B, Prestwich GD, Rao S, Lerro KA, Horwitz SB.

J Med Chem. 1995 Sep 29;38(20):3891-4. No abstract available.

PMID:
7562921
19.

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

Dey S, Ramachandra M, Pastan I, Gottesman MM, Ambudkar SV.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10594-9.

20.

Iodomycin and iodipine, a structural analogue of azidopine, bind to a common domain in hamster P-glycoprotein.

Demmer A, Andreae S, Thole H, Tümmler B.

Eur J Biochem. 1999 Sep;264(3):800-5.

Supplemental Content

Support Center